DTIM
XBI icon

Danda Trouve Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Danda Trouve Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$22K – 181
2020
Q2 		$22K Buy
+200
New +$19.7K 0.03% 74

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danda Trouve Investment Management's XBI Position: Q3 2020 in Review

Danda Trouve Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2020, closing a stake of 200 shares — an estimated $22K sold.

Danda Trouve Investment Management first reported a position in XBI in Q2 2020 and held it in 1 quarter. The position peaked at $22K in Q2 2020. 554 funds tracked by Wall St. Rank hold XBI as of Q3 2020.

  • Danda Trouve Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2020 after selling out during the quarter.
  • Danda Trouve Investment Management sold 200 State Street SPDR S&P Biotech ETF shares in Q3 2020, an estimated $22K.
  • Danda Trouve Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 1 quarter.
  • Danda Trouve Investment Management's State Street SPDR S&P Biotech ETF position peaked at $22K in Q2 2020.
  • 554 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2020.

Based on Danda Trouve Investment Management's 13F filing for Q3 2020, filed 28 Oct 2020.